Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Effects of Tinzaparin sodium on Cardio-vascular OUtcomes and on blood Lipids in Diabetic patients on Chronic HEmodialysis: a Long-term, Prospective study (The 'Tinzaparin COULD HELP' study)

Trial Profile

Effects of Tinzaparin sodium on Cardio-vascular OUtcomes and on blood Lipids in Diabetic patients on Chronic HEmodialysis: a Long-term, Prospective study (The 'Tinzaparin COULD HELP' study)

Withdrawn prior to enrolment
Phase of Trial: Phase IV

Latest Information Update: 29 Dec 2017

At a glance

  • Drugs Tinzaparin sodium (Primary) ; Heparin
  • Indications Thrombosis
  • Focus Pharmacodynamics
  • Acronyms Tinzaparin COULD HELP
  • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 21 Dec 2017 Status changed from suspended to withdrawn prior to enrolment.
    • 24 Jan 2017 Planned End Date changed from 1 Dec 2013 to 1 Jan 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top